UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estrogen Action Via the G Protein-Coupled Receptor, GPR30: Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis

Molecular endocrinology (Baltimore, Md.), 2002-01, Vol.16 (1), p.70-84

2002

Volltextzugriff (PDF)

Coordinate Regulation of Estrogen-Mediated Fibronectin Matrix Assembly and Epidermal Growth Factor Receptor Transactivation by the G Protein-Coupled Receptor, GPR30

Molecular endocrinology (Baltimore, Md.), 2009-07, Vol.23 (7), p.1052-1064

2009

Volltextzugriff (PDF)

p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer

Clinical cancer research, 2007-10, Vol.13 (19), p.5798-5804

2007

Volltextzugriff (PDF)

Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer

Cancer research (Chicago, Ill.), 2003-10, Vol.63 (20), p.6772-6783

2003

Volltextzugriff (PDF)

Estrogen-Induced Activation of Erk-1 and Erk-2 Requires the G Protein-Coupled Receptor Homolog, GPR30, and Occurs via Trans-Activation of the Epidermal Growth Factor Receptor through Release of HB-EGF

Molecular endocrinology (Baltimore, Md.), 2000-10, Vol.14 (10), p.1649-1660

2000

Volltextzugriff (PDF)

The Critical Role of Shc in Insulin-Like Growth Factor-I-Mediated Mitogenesis and Differentiation in 3T3-L1 Preadipocytes

Molecular endocrinology (Baltimore, Md.), 2000-06, Vol.14 (6), p.805-813

2000

Volltextzugriff (PDF)

Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis

Molecular endocrinology (Baltimore, Md.), 2002-01, Vol.16 (1), p.70-84

2002

Volltextzugriff (PDF)

p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy

Breast cancer research : BCR, 2006-01, Vol.8 (6), p.R73-R73, Article R73

2006

Volltextzugriff (PDF)

Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the RAS signaling pathway

International journal of cancer, 1996-01, Vol.65 (2), p.186-191

1996

Volltextzugriff (PDF)

Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells : Correlation with ErbB2 and p66 Shc expression

Breast cancer research and treatment, 1998-05, Vol.49 (2), p.119-128

1998

Volltextzugriff (PDF)

Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model

Cancer, 1999-11, Vol.86 (9), p.1733-1741

1999

Volltextzugriff (PDF)

Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance

The Prostate, 1999-08, Vol.40 (3), p.178-191

1999

Volltextzugriff (PDF)

Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo

Cancer research (Chicago, Ill.), 1992-01, Vol.52 (1), p.227-230

1992

Volltextzugriff (PDF)

Differentiation-induced changes in protein-tyrosine phosphatase activity and commensurate expression of CD45 in human leukemia cell lines

Cancer research (Chicago, Ill.), 1992-07, Vol.52 (14), p.4027-4035

1992

Volltextzugriff (PDF)

Platelet-derived growth factor indirectly stimulates angiogenesis in vitro

The American journal of pathology, 1993-04, Vol.142 (4), p.1119-1130

1993

Volltextzugriff (PDF)

Human Microvascular Endothelial Cells Express Receptors for Platelet- Derived Growth Factor

Proceedings of the National Academy of Sciences - PNAS, 1991-03, Vol.88 (5), p.2021-2025

1991

Volltextzugriff (PDF)

Abelson-transformed fibroblasts contain nuclear phosphotyrosyl-proteins which preferentially bind to murine DNA

Nature (London), 1987-02, Vol.325 (6104), p.552-554

1987

Volltextzugriff (PDF)

Human monoclonal antibodies reactive with human myelomonocytic leukemia cells

Cancer research (Chicago, Ill.), 1989-04, Vol.49 (7), p.1665-1670

1989

Volltextzugriff (PDF)

Protein-tyrosine kinase activity and pp60v-src expression in whole cells measured by flow cytometry

Cancer research (Chicago, Ill.), 1988-08, Vol.48 (16), p.4633-4638

1988

Volltextzugriff (PDF)

Identification of tyrosine-phosphorylated colony-stimulating factor 1 (CSF-1) receptor and a 56-kilodalton protein phosphorylated in intact human cells in response to CSF-1

Journal of cellular biochemistry, 1989-02, Vol.39 (2), p.129-137

1989

Volltextzugriff (PDF)

Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo

Anticancer research, 1999-05, Vol.19 (3A), p.1705

1999

Volltextzugriff (PDF)

The Mitotoxin, Basic Fibroblast Growth Factor-Saporin, Effectively Targets Human Prostatic Carcinoma in an Animal Model

The Journal of urology, 1996-09, p.1174-1179

1996

Volltextzugriff (PDF)

The Mitotoxin, Basic Fibroblast Growth Factor-Saporin, Effectively Targets Human Prostatic Carcinoma in an Animal Model

The Journal of urology, 1996-09, Vol.156 (3), p.1174-1179

1996

Volltextzugriff (PDF)

Identification and Subcellular Localization of Proteins that are Rapidly Phosphorylated in Tyrosine in Response to Colony-Stimulating Factor 1

Proceedings of the National Academy of Sciences - PNAS, 1988-11, Vol.85 (21), p.8062-8066

1988

Volltextzugriff (PDF)

Tumor Promoters Block Tyrosine-Specific Phosphorylation of the Epidermal Growth Factor Receptor

Proceedings of the National Academy of Sciences - PNAS, 1984-05, Vol.81 (10), p.3034-3038

1984

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(47)
Dissertationen
(2)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Humans
(27)
Life Sciences & Biomedicine
(26)
Biological And Medical Sciences
(24)
Animals
(20)
Medical Sciences
(14)
Oncology
(14)
Mice
(12)
Tumor Cells, Cultured
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Female
(9)
Pharmacology. Drug Treatments
(9)
Phosphorylation
(9)
Antineoplastic Agents
(8)
Phosphotyrosine
(8)
Molecular And Cellular Biology
(7)
Ribosome Inactivating Proteins, Type 1
(7)
Tyrosine - Analogs & Derivatives
(7)
Breast Neoplasms - Metabolism
(6)
Male
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Estrogen Action Via the G Protein-Coupled Receptor, GPR30: Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis

Coordinate Regulation of Estrogen-Mediated Fibronectin Matrix Assembly and Epidermal Growth Factor Receptor Transactivation by the G Protein-Coupled Receptor, GPR30

p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer

Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer

Estrogen-Induced Activation of Erk-1 and Erk-2 Requires the G Protein-Coupled Receptor Homolog, GPR30, and Occurs via Trans-Activation of the Epidermal Growth Factor Receptor through Release of HB-EGF

The Critical Role of Shc in Insulin-Like Growth Factor-I-Mediated Mitogenesis and Differentiation in 3T3-L1 Preadipocytes

Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis

p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy

Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the RAS signaling pathway

Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells : Correlation with ErbB2 and p66 Shc expression

Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model

Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance

Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo

Differentiation-induced changes in protein-tyrosine phosphatase activity and commensurate expression of CD45 in human leukemia cell lines

Platelet-derived growth factor indirectly stimulates angiogenesis in vitro

Human Microvascular Endothelial Cells Express Receptors for Platelet- Derived Growth Factor

Abelson-transformed fibroblasts contain nuclear phosphotyrosyl-proteins which preferentially bind to murine DNA

Human monoclonal antibodies reactive with human myelomonocytic leukemia cells

Protein-tyrosine kinase activity and pp60v-src expression in whole cells measured by flow cytometry

Identification of tyrosine-phosphorylated colony-stimulating factor 1 (CSF-1) receptor and a 56-kilodalton protein phosphorylated in intact human cells in response to CSF-1

Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo

The Mitotoxin, Basic Fibroblast Growth Factor-Saporin, Effectively Targets Human Prostatic Carcinoma in an Animal Model

The Mitotoxin, Basic Fibroblast Growth Factor-Saporin, Effectively Targets Human Prostatic Carcinoma in an Animal Model

Identification and Subcellular Localization of Proteins that are Rapidly Phosphorylated in Tyrosine in Response to Colony-Stimulating Factor 1

Tumor Promoters Block Tyrosine-Specific Phosphorylation of the Epidermal Growth Factor Receptor

Suchergebnisse filtern